drugset / Trial / NCT05990621
Anti-CD70 CAR-T Cell Injection in Patients With CD70-positive Advanced Urologic Neoplasms
NaSingle-groupOpen-labelTreatment
Summary
This is a single-arm, open-label, exploratory clinical study to evaluate the safety, tolerability and preliminary efficacy of Anti-CD70 CAR-T cell injection in patients with CD70-positive Advanced Urologic Neoplasms.
Timeline
- Start
- 2023-07-31
- Primary completion
- 2026-01-31
- Completion
- 2026-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Anti-CD70 CAR-T cells | Cell therapy | 600000 cells/kg | Intravenous |
| Subject | Anti-CD70 CAR-T cells | Cell therapy | 5e+06 cells/kg | Intravenous |